GB0114008D0 - New therapautic use - Google Patents

New therapautic use

Info

Publication number
GB0114008D0
GB0114008D0 GBGB0114008.6A GB0114008A GB0114008D0 GB 0114008 D0 GB0114008 D0 GB 0114008D0 GB 0114008 A GB0114008 A GB 0114008A GB 0114008 D0 GB0114008 D0 GB 0114008D0
Authority
GB
United Kingdom
Prior art keywords
therapautic
new
therapautic use
new therapautic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0114008.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PERRY ROBERT E
Original Assignee
PERRY ROBERT E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PERRY ROBERT E filed Critical PERRY ROBERT E
Priority to GBGB0114008.6A priority Critical patent/GB0114008D0/en
Publication of GB0114008D0 publication Critical patent/GB0114008D0/en
Priority to MXPA03011226A priority patent/MXPA03011226A/es
Priority to PCT/GB2002/002635 priority patent/WO2002100414A1/en
Priority to JP2003503235A priority patent/JP2005500285A/ja
Priority to CA002449957A priority patent/CA2449957A1/en
Priority to CNB028129687A priority patent/CN1234367C/zh
Priority to US10/478,977 priority patent/US20040242547A1/en
Priority to ZA200309473A priority patent/ZA200309473B/xx
Priority to AU2002311445A priority patent/AU2002311445B2/en
Priority to BR0210195-5A priority patent/BR0210195A/pt
Priority to RU2004100228/15A priority patent/RU2004100228A/ru
Priority to KR10-2003-7015978A priority patent/KR20040030654A/ko
Priority to EP02738362A priority patent/EP1399167A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0114008.6A 2001-06-08 2001-06-08 New therapautic use Ceased GB0114008D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0114008.6A GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use
EP02738362A EP1399167A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
US10/478,977 US20040242547A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
PCT/GB2002/002635 WO2002100414A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
JP2003503235A JP2005500285A (ja) 2001-06-08 2002-06-07 腹圧性尿失禁の治療のためのアリールアゾ−置換イミダゾール
CA002449957A CA2449957A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
CNB028129687A CN1234367C (zh) 2001-06-08 2002-06-07 用于压迫性尿失禁治疗的芳基偶氮－取代的咪唑
MXPA03011226A MXPA03011226A (es) 2001-06-08 2002-06-07 Imidazol sustituido con arilazo para el tratamiento de incontinencia urinaria por estres.
ZA200309473A ZA200309473B (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence.
AU2002311445A AU2002311445B2 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
BR0210195-5A BR0210195A (pt) 2001-06-08 2002-06-07 Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão
RU2004100228/15A RU2004100228A (ru) 2001-06-08 2002-06-07 Замещенный арилазоимидазол для лечения недержания мочи при напряжении
KR10-2003-7015978A KR20040030654A (ko) 2001-06-08 2002-06-07 스트레스성 요실금 치료용 아릴아조-치환 이미다졸

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0114008.6A GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use

Publications (1)

Publication Number Publication Date
GB0114008D0 true GB0114008D0 (en) 2001-08-01

Family

ID=9916211

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0114008.6A Ceased GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use

Country Status (13)

Country Link
US (1) US20040242547A1 (enExample)
EP (1) EP1399167A1 (enExample)
JP (1) JP2005500285A (enExample)
KR (1) KR20040030654A (enExample)
CN (1) CN1234367C (enExample)
AU (1) AU2002311445B2 (enExample)
BR (1) BR0210195A (enExample)
CA (1) CA2449957A1 (enExample)
GB (1) GB0114008D0 (enExample)
MX (1) MXPA03011226A (enExample)
RU (1) RU2004100228A (enExample)
WO (1) WO2002100414A1 (enExample)
ZA (1) ZA200309473B (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056123B2 (ja) * 1979-07-30 1985-12-09 持田製薬株式会社 浮腫・低血圧・心不全および粘膜充血治療用剤
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US6323231B1 (en) * 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence

Also Published As

Publication number Publication date
CN1234367C (zh) 2006-01-04
JP2005500285A (ja) 2005-01-06
ZA200309473B (en) 2005-03-23
RU2004100228A (ru) 2005-06-10
EP1399167A1 (en) 2004-03-24
AU2002311445B2 (en) 2005-08-25
CA2449957A1 (en) 2002-12-19
WO2002100414A1 (en) 2002-12-19
CN1541099A (zh) 2004-10-27
US20040242547A1 (en) 2004-12-02
BR0210195A (pt) 2004-07-27
MXPA03011226A (es) 2004-03-26
KR20040030654A (ko) 2004-04-09

Similar Documents

Publication Publication Date Title
DE60237965D1 (en) Metalloproteinaseinhibitoren
DE60231477D1 (en) Imidazolderivate
DE60210819D1 (en) Pyrazolopyridazinderivate
DE60141362D1 (en) Ösophagus-stoma-knopf
EP1387687A4 (en) NEW USE
DE60218514D1 (en) Polyolefin-kunststoffrohre
GB0125088D0 (en) New use
GB0115181D0 (en) Novel use
GB0100762D0 (en) Novel use
GB0104554D0 (en) New uses
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
HUP0303329A3 (en) New phenylpiperzines
DE50214962D1 (en) Heterocyclylarylsulfonamide
GB0106031D0 (en) Use
PL364090A1 (en) New benzylaminopyrimidines
GB0119920D0 (en) New use
GB0112208D0 (en) New use
GB0115989D0 (en) New use
GB0129834D0 (en) New use
GB0119928D0 (en) New use
GB0119822D0 (en) New use
GB0119693D0 (en) New Use
GB0114008D0 (en) New therapautic use
GB0117918D0 (en) New use
GB0112207D0 (en) New use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)